Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen

This study has been completed.
Sponsor:
Collaborator:
SGS Aster-Cephac (CRO)
Information provided by:
Immutep S.A.
ClinicalTrials.gov Identifier:
NCT00354263
First received: July 19, 2006
Last updated: April 23, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2006
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)